Drug-Associated Gastropathy: Diagnostic Criteria
Diagnostics · 29.06.2023 · 13 (13) · 2220
DOI: 10.3390/diagnostics13132220 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 29.06.2023. Verfasst von Dmitry S Bordin und 4 weiteren Autor:innen. Beteiligte Einrichtung: A.S. Loginov Moscow Clinical Scientific Center, Department of Pancreatic, Biliary and Upper Digestive Tract Disorders, 111123 Moscow, Russia. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Drugs are widely used to treat different diseases in modern medicine, but they are often associated with adverse events. Those located in the gastrointestinal tract are common and often mild, but they can be serious or life-threatening and determine the continuation of treatment. The stomach is often affected not only by drugs taken orally but also by those administered parenterally. Here, we review the mechanisms of damage, risk factors and specific endoscopic, histopathological and clinical features of those drugs more often involved in gastric damage, namely NSAIDs, aspirin, anticoagulants, glucocorticosteroids, anticancer drugs, oral iron preparations and proton pump inhibitors. NSAID- and aspirin-associated forms of gastric damage are widely studied and have specific features, although they are often hidden by the coexistence of Helicobacter pylori infection. However, the damaging effect of anticoagulants and corticosteroids or oral iron therapy on the gastric mucosa is controversial. At the same time, the increased use of new antineoplastic drugs, such as checkpoint inhibitors, has opened up a new area of gastrointestinal damage that will be seen more frequently in the near future. We conclude that there is a need to expand and understand drug-induced gastrointestinal damage to prevent and recognize drug-associated gastropathy in a timely manner.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- A.S. Loginov Moscow Clinical Scientific Center, Department of Pancreatic, Biliary and Upper Digestive Tract Disorders, 111123 Moscow, Russia.
- Department of Propaedeutic of Internal Diseases and Gastroenterology, A.I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia.
- Department of Outpatient Therapy and Family Medicine, Tver State Medical University, 170100 Tver, Russia.
- Department of Faculty Therapy and Gastroenterology, Omsk Sate Medical University, 644099 Omsk, Russia.
- Department of Pathological Anatomy, Omsk Sate Medical University, 644099 Omsk, Russia.
- Digestive Diseases Service, Aragón Health Research Institute (IIS Aragón), University Clinic Hospital, University of Zaragoza, 50009 Zaragoza, Spain.
ORCID-Profile: Dmitry S Bordin, Maria A Livzan, Olga V Gaus, Sergei I Mozgovoi, Angel Lanas
Zitieren
APA
Bordin, D. S., Livzan, M. A., Gaus, O. V., Mozgovoi, S. I., & Lanas, A. (2023). Drug-Associated Gastropathy: Diagnostic Criteria. Diagnostics, 13(13), 2220. https://doi.org/10.3390/diagnostics13132220
Vancouver
Bordin DS, Livzan MA, Gaus OV, Mozgovoi SI, Lanas A. Drug-Associated Gastropathy: Diagnostic Criteria. Diagnostics. 2023;13(13):2220. doi:10.3390/diagnostics13132220
BibTeX
@article{Bordin2023,
author = {Bordin, Dmitry S and Livzan, Maria A and Gaus, Olga V and Mozgovoi, Sergei I and Lanas, Angel},
title = {Drug-Associated Gastropathy: Diagnostic Criteria},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {13},
pages = {2220},
doi = {10.3390/diagnostics13132220}
}
EUVIMED